CYTOKINETICS INC cotiza a 62.79 USD y tiene una capitalización bursátil de $8.7B. En los últimos 12 meses ha facturado $68M con un margen de flujo de caja libre del -607.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor f…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.50 | $-1.67 | $-1.50 |
| Estimado | $-1.43 | $-1.61 | $-1.65 | $-1.37 |
| Sorpresa | — | +6.8% | -1.2% | -9.5% |
| Métrica | CYTK | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -695.4% | -38.6% | -656.8% |
| Net Margin | -891.6% | -33.6% | -858.0% |
| FCF Margin | -607.5% | -13.9% | -593.6% |
| ROE | — | -40.4% | — |
| ROA | -55.1% | -32.0% | -23.1% |
| Current Ratio | 4.53 | 2.84 | +1.69 |
| Debt / Equity | -0.37 | 0.28 | -0.65 |